MedPath

Efficacy of Tobacco Quitline for Cancer Survivors

Not Applicable
Completed
Conditions
Smoking Cessation
Interventions
Other: Self-Paced Tobacco Quit Line
Other: Counselor-Initiated Tobacco Quit Line
Registration Number
NCT00827866
Lead Sponsor
St. Jude Children's Research Hospital
Brief Summary

The proposed study is a two-armed randomized controlled clinical trial examining the long-term (one-year) efficacy of telephone intervention conditions for smoking cessation in a high risk medical population; namely, cancer survivors: Proactive telephone recruitment through the Childhood Cancer Survivors Survey (CCSS) St. Jude Life Study, After Completion of Therapy (ACT) Clinic and face to face recruitment at the local West Clinics will serve as the primary methods of recruitment.

The specific aims of the study :

(1) To recruit nationally a cohort of approximately 1242 smokers who are cancer survivors(621 childhood cancer survivors and 621 adult cancer survivors); 2) To determine the long-term (one year) efficacy of the intervention condition for participants randomly assigned to the Counselor-initiated versus a Self-paced QL; and (3) to find out whether treatment outcomes vary as a function of survivors' age of cancer diagnosis (survivors who diagnosed while adults vs. childhood cancer survivors who diagnosed before the age of 21).

Detailed Description

In this study participants (n=1242) will be randomly assigned to a Counselor-Initiated Tobacco Quit Line (QL;) in which the counselor contacts the client with the standardized intervention protocol, or a Self-Paced Tobacco QL (which leaves the calling up to participants).The proposed active intervention will be a the Counselor-Initiated QL which includes 8 weeks of nicotine replacement therapy (NRT) and six scheduled telephone sessions of a behavioral intervention. The comparison condition will be the Self-Paced QL with provision of 2 weeks of NRT and encouraged obtainment of additional NRT. If participants in the Self-Paced condition make all six calls, they will receive the same behavioral intervention as in the Counselor-Initiated condition.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
946
Inclusion Criteria
  • Participants smokes cigarettes
  • Participants is a cancer survivor
  • Participant must be at least 18 years of age.
  • Childhood cancer survivors must be at least one year out active cancer treatment.
  • Participant understands consent procedures.
  • Participant speaks English.
  • Participant must have access to a telephone for participation
Exclusion Criteria
  • Inability to understand consent procedures
  • Participants with a known contraindication or sensitivity to nicotine replacement therapy may participate in this study; however they will not receive nicotine replacement therapy (NRT) as part of their smoking cessation program.
  • Since our participants are childhood cancer survivors and they can be medically fragile and we are interested in providing all eligible participants with NRT to enhance their ability to quit smoking, we added a cautionary conditions list to the recruitment screening form. Those with severe arrhythmias, myocardial infarction, unstable angina, cerebrovascular incident, blood vessel disease, phaeochromocytoma, diabetes, hyperthyroidism, abnormal kidney or liver function, or history of gastritis or peptic ulcers, or who smoke less than 5 cigarettes per day will not receive NRT.
  • Patients with questionable NRT eligibility will be discussed/reviewed on a case by case basis with the Staff Family Physician

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2Self-Paced Tobacco Quit LineSelf-Paced Tobacco Quit Line Group which leaves the calling up to participants
1Counselor-Initiated Tobacco Quit LineCounselor-Initiated Tobacco Quit Line Group QL where the counselor contacts the client with a standardized intervention protocol)
Primary Outcome Measures
NameTimeMethod
Self-reported prolonged abstinence and cotinine-validated point-prevalence abstinence at 1 year follow-up1 year
Secondary Outcome Measures
NameTimeMethod
Account for dose of treatment (NRT use plus number of QL contact) vs. success(quit for one year response) independent of treatment assignment1 year

Trial Locations

Locations (1)

St. Jude Children's Research Hospital

🇺🇸

Memphis, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath